Product Reports Resources Pricing Login Book a demo

Luminex

Biotech & Life Sciences · Austin, United States · Founded 1995

We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, flow cytometry and imaging, genomic and proteomic research, and food safety

Valuation $1–2.5B
Revenue $500M–1B
Headcount 1–2k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Luminex and the history behind them.
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Luminex's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Luminex mafia

Startups founded by Luminex alumni

Former Luminex employees who went on to start their own companies. Sorted by Dealroom signal score.

Pattern BioscienceEst. 2016
Nicolas ArabUnited States
Signal score89
A-Alpha BioEst. 2017
DYDavid YoungerUnited States
Signal score67
Intelligent ImplantsEst. 2014
JPJuan PardoSweden
Signal score65
Paratus DiagnosticsEst. 2012
John C. CarranoUnited States
Signal score52
Consortia HealthEst. 2012
Gail PageUnited States
Signal score46

Book a demo to explore the full alumni network →

Global footprint

Where Luminex has talent and traffic

Workforce by country
16 countries with
team presence
🇺🇸 United States82.4%
🇨🇦 Canada7.7%
🇳🇱 Netherlands2.6%
🇨🇳 China2.3%
🇬🇧 United Kingdom1.3%
Top 5 of 16 shown

Patent intelligence

Luminex’s patent portfolio

Estimated portfolio value
$142M

71 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Capital deployed

Luminex's 3 investments and acquisitions.

Every disclosed deal where Luminex appeared as a backer or acquirer, 2011–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Luminex's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Luminex deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Luminex's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Luminex

        An AI-synthesized read of the highest-engagement posts about Luminex on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Luminex on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles